Bionovate Technologies (BIIO) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 0 13 sessions, November 3, 2025 to August 20, 2026
- Largest daily move
- +0% close of November 28, 2025
- 1-month change
- +0% closing prices, July 1, 2026 to August 20, 2026
Company Description
Bionovate Technologies (OTC: BIIO) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $775.0.
BIIO has gained 0.0% over the past month. The last closing price was $0.0001.
This page collects what Stock Titan holds for BIIO, including price data, latest news, and short interest trends.
Stock Performance
Bionovate Technologies (BIIO) closed at $0.0001 on August 20, 2026. Over the past month, the price has gained 0.0%.
BIIO Metrics & Rankings
Price returns through August 20, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Bionovate Technologies has 4 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 0 with negative movement. View all BIIO news →
SEC Filings
Short Interest History
Short interest in Bionovate Technologies (BIIO) currently stands at 51 shares, representing 0.0% of the float.
Days to Cover History
Days to cover for Bionovate Technologies (BIIO) currently stands at 1000.0 days, up 99899% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 99899%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
BIIO Company Profile & Sector Positioning
Bionovate Technologies (BIIO) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing BIIO often look at related companies in the same sector, including Minerva Surgical Inc New (UTRS), STRATA Skin Sciences Inc (SSKN), Motus GI Holdings Inc (MOTS), ThermoGenesis Holdings Inc (THMO), and Viveve Medical Inc (VIVE). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BIIO's relative position within its industry.